Search research articles
Contact Us
Filters
Showing results (91-100 of 124) with videos related to
Page
of 13
Sort By:
Neuropathology and Applied Neurobiology
|
July 13, 2010
Evaluation of potential synergistic action of a combined treatment with alpha-methyl-prednisolone and taurine on the mdx mouse model of Duchenne muscular dystrophy
A Cozzoli, J-F Rolland, R F Capogrosso, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity
|
December 4, 2002
Body mass index in 7-9-y-old French children: frequency of obesity, overweight and thinness
M-F Rolland-Cachera, K Castetbon, N Arnault, et al.
FEMS Yeast Research
|
April 19, 2003
The role of hexose transport and phosphorylation in cAMP signalling in the yeast Saccharomyces cerevisiae
F Rolland, V Wanke, L Cauwenberg, et al.
Scientific Reports
|
March 22, 2017
A new electro-optical approach for conductance measurement: an assay for the study of drugs acting on ligand-gated ion channels
A Menegon, S Pitassi, N Mazzocchi, et al.
Bulletin Du Cancer
|
September 1, 1995
[Randomized placebo trial of myeloprotection with goralatide in patients with squamous cell carcinoma of the upper respiratory and digestive tracts or esophagus, treated with a carboplatin-fluorouracil combination]
P Cappelaere, B Hecquet, F Rolland, et al.
British Journal of Cancer
|
April 20, 2006
A phase II study of vinflunine in bladder cancer patients progressing after first-line platinum-containing regimen
S Culine, C Theodore, M De Santis, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity
|
February 18, 2004
Massive obesity in adolescents: dietary interventions and behaviours associated with weight regain at 2 y follow-up
M F Rolland-Cachera, H Thibault, J C Souberbielle, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 2, 2004
Phase II study of OSI-211 (liposomal lurtotecan) in patients with metastatic or loco-regional recurrent squamous cell carcinoma of the head and neck. An EORTC New Drug Development Group study
F Duffaud, M Borner, P Chollet, et al.
Molecular Oncology
|
November 15, 2012
Optimize radiochemotherapy in pancreatic cancer: PARP inhibitors a new therapeutic opportunity
Letizia Porcelli, Anna E Quatrale, Paola Mantuano, et al.
Bulletin Du Cancer
|
July 1, 1996
[Predictive value of the hemogram for myelotoxicity induced by the association of carboplatin-fluorouracil on the 4th day of the therapeutic regimen]
P Cappelaere, C Fournier, F Rolland, et al.
Page
of 13
Search research articles
Search
Showing results (91-100 of 124) with videos related to
Sort By:
Page
of 13
Neuropathology and Applied Neurobiology
|
July 13, 2010
Evaluation of potential synergistic action of a combined treatment with alpha-methyl-prednisolone and taurine on the mdx mouse model of Duchenne muscular dystrophy
A Cozzoli, J-F Rolland, R F Capogrosso, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity
|
December 4, 2002
Body mass index in 7-9-y-old French children: frequency of obesity, overweight and thinness
M-F Rolland-Cachera, K Castetbon, N Arnault, et al.
FEMS Yeast Research
|
April 19, 2003
The role of hexose transport and phosphorylation in cAMP signalling in the yeast Saccharomyces cerevisiae
F Rolland, V Wanke, L Cauwenberg, et al.
Scientific Reports
|
March 22, 2017
A new electro-optical approach for conductance measurement: an assay for the study of drugs acting on ligand-gated ion channels
A Menegon, S Pitassi, N Mazzocchi, et al.
Bulletin Du Cancer
|
September 1, 1995
[Randomized placebo trial of myeloprotection with goralatide in patients with squamous cell carcinoma of the upper respiratory and digestive tracts or esophagus, treated with a carboplatin-fluorouracil combination]
P Cappelaere, B Hecquet, F Rolland, et al.
British Journal of Cancer
|
April 20, 2006
A phase II study of vinflunine in bladder cancer patients progressing after first-line platinum-containing regimen
S Culine, C Theodore, M De Santis, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity
|
February 18, 2004
Massive obesity in adolescents: dietary interventions and behaviours associated with weight regain at 2 y follow-up
M F Rolland-Cachera, H Thibault, J C Souberbielle, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 2, 2004
Phase II study of OSI-211 (liposomal lurtotecan) in patients with metastatic or loco-regional recurrent squamous cell carcinoma of the head and neck. An EORTC New Drug Development Group study
F Duffaud, M Borner, P Chollet, et al.
Molecular Oncology
|
November 15, 2012
Optimize radiochemotherapy in pancreatic cancer: PARP inhibitors a new therapeutic opportunity
Letizia Porcelli, Anna E Quatrale, Paola Mantuano, et al.
Bulletin Du Cancer
|
July 1, 1996
[Predictive value of the hemogram for myelotoxicity induced by the association of carboplatin-fluorouracil on the 4th day of the therapeutic regimen]
P Cappelaere, C Fournier, F Rolland, et al.
Page
of 13